Leukemia is a rare event in pregnancy. Acute leukemia represents % of leukemias occurring during pregnancy with AML accounting for two thirds of these cases.During the first trimester of pregnancy, standard chemotherapy has a teratogenicity rate of up to % depending on the specific agent employed. Exposure to cytotoxic agents during the second and third trimesters is not teratogenic but may predispose the fetus to growth retardation, premature delivery and bone marrow suppression.Additionally, the mother and the fetus are at risk of thromboembolism and sepsis.